-
121
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy
Published 2016-01-01“…Cannabis and related compounds have created significant research interest as a promising therapy in neurodegenerative and movement disorders. In this review we examine the potential benefits of medical marijuana and related compounds in the treatment of both motor and nonmotor symptoms as well as in slowing the progression of the disease. …”
Get full text
Article -
122
Generation of an induced pluripotent stem cell line (UCLi026-A) from a patient with ADCY5-related disease carrying the heterozygous variant c.1253G > A; (p. Arg418Gln)
Published 2025-04-01“…Heterozygous mutations in ADCY5 lead to ADCY5-related dyskinesia, comprising a wide array of disabling hyperkinetic movement disorders including chorea, myoclonus and/or dystonia. …”
Get full text
Article -
123
-
124
-
125
The Future of Research in Tourette Syndrome
Published 2013-01-01“…Although there has been a paucity of research on TS compared to other movement disorders, in recent years TS has garnered increasing interest and has shown a number of novel and complex sides, about which much is yet to be learnt. …”
Get full text
Article -
126
Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s Disease
Published 2020-01-01Get full text
Article -
127
Anti-N-Methyl-D-Aspartate Encephalitis as Paraneoplastic Manifestation of Germ-Cells Tumours: A Cases Report and Literature Review
Published 2019-01-01“…There is a wide spectrum of clinical features starting by a viral-like prodrome, followed by symptoms such as psychosis, aggressive behaviour, memory loss, seizures, movement disorders, and autonomic instability. Up to 50% of the affected young female patients have germ-cells tumours as ovarian teratoma, making it essential to establish an early diagnosis through detection of specific antibodies in serum and cerebrospinal fluid (CSF). …”
Get full text
Article -
128
Gaitmap—An Open Ecosystem for IMU-Based Human Gait Analysis and Algorithm Benchmarking
Published 2024-01-01“…<italic>Goal:</italic> Gait analysis using inertial measurement units (IMUs) has emerged as a promising method for monitoring movement disorders. However, the lack of public data and easy-to-use open-source algorithms hinders method comparison and clinical application development. …”
Get full text
Article -
129
The endocytic adaptor AP-2 maintains Purkinje cell function by balancing cerebellar parallel and climbing fiber synapses
Published 2025-02-01“…Summary: The loss of cerebellar Purkinje cells is a hallmark of neurodegenerative movement disorders, but the mechanisms remain enigmatic. …”
Get full text
Article -
130
Dysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson’s Disease Patients
Published 2016-01-01“…An observational cross-sectional study was carried out using 105 Parkinson’s disease (PD) patients of the Movement Disorders Unit, Hospital de Cruces (Bilbao, Spain) [men 59 (56.2%), women 46 (43.85%)]. …”
Get full text
Article -
131
-
132
Thyroid-Induced Worsening of Parkinsonian Tremor Resistant to Drugs and Subthalamic Nucleus Deep Brain Stimulation
Published 2014-01-01“…A hyperthyroid state can markedly exaggerate all forms of tremor, as well as other types of movement disorders. This condition can be overlooked or masked by other symptoms. …”
Get full text
Article -
133
Iron Accumulation Is Not Homogenous among Patients with Parkinson’s Disease
Published 2015-01-01“…Twelve de novo patients with PD were recruited from the Movement Disorders Clinic, Department of Neurology, Loma Linda University. …”
Get full text
Article -
134
A Corticobasal Syndrome Variant of Familial Creutzfeldt-Jakob Disease with Stroke-Like Onset
Published 2016-01-01“…Creutzfeldt-Jakob disease (CJD) is an untreatable rare human prion disease characterized by rapidly progressive dementia along with various neurological features, including myoclonus and sometimes other movement disorders. The clinical course is typically insidious and rapid, leading to an early death. …”
Get full text
Article -
135
-
136
Multidisciplinary, multicenter consensus for the care of patients affected with Sturge–Weber syndrome
Published 2025-01-01Get full text
Article -
137
Early Infantile Epileptic Encephalopathy in an STXBP1 Patient with Lactic Acidemia and Normal Mitochondrial Respiratory Chain Function
Published 2016-01-01“…A wide range of clinical findings have been associated with mutations in Syntaxin Binding Protein 1 (STXBP1), including multiple forms of epilepsy, nonsyndromic intellectual disability, and movement disorders. STXBP1 mutations have recently been associated with mitochondrial pathology, although it remains unclear if this phenotype is a part of the core feature for this gene disorder. …”
Get full text
Article -
138
Neuromodulation: clinical advances and future perspectives
Published 2025-01-01“…It analyzes their efficacy and potential in the fields of movement disorders, epilepsy, pain, cognitive impairment, and neurorehabilitation. …”
Get full text
Article -
139
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes
Published 2022-06-01“…It causes significant morbidity and disability through a plethora of symptoms, including movement disorders, sleep disturbances, and cognitive and psychiatric symptoms. …”
Get full text
Article -
140
Impact of External Cue Validity on Driving Performance in Parkinson's Disease
Published 2011-01-01Get full text
Article